Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nocera, Inc. (NASDAQ: NCRA) is a diversified holding company that historically focused on sustainable aquaculture, specifically the design, development, and production of land-based Recirculating Aquaculture Systems (RAS) for fish farming. In May 2026, the company announced a major strategic transformation into Nocera Holdings, expanding its focus to high-growth technology sectors including artificial intelligence, AI infrastructure, robotics, blockchain, digital assets, and biotechnology. As part of this pivot, Nocera is actively evaluating strategic investments, partnerships, and acquisition opportunities within the biotech and AI-driven healthcare sectors, specifically targeting diagnostics, automation, and AI-enabled operational platforms. The company operates internationally with its principal offices located in New Taipei City, Taiwan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nocera.